EA
DFTX

Emerald Advisers’s Definium Therapeutics DFTX Stock Holding History

Emerald Advisers’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.41M Buy
+178,751
New +$4.42M 0.2% 111

Other funds holding DFTX

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Emerald Advisers's DFTX Position: Q2 2026 in Review

Emerald Advisers opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 178,751 shares worth $8.41M. The stake represents 0.2% of the portfolio and ranks #111 among its holdings.

102 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Emerald Advisers held 178,751 shares of Definium Therapeutics worth $8.41M as of Q2 2026.
  • Definium Therapeutics was a new Emerald Advisers position in Q2 2026.
  • Definium Therapeutics made up 0.2% of Emerald Advisers's portfolio in Q2 2026, its #111 holding.
  • 102 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.